Randomized Controlled Trials for PT: The Gold Standard Artwork

Campus PEPtalk

Compared to other cancer treatments, proton therapy is one of the most promising forms of cancer therapy. Join IBA as we interview key opinion leaders in the field and share knowledge of our purpose-led pursuit to eliminate cancer. Each episode will focus on a powerful story about pushing the boundaries of scientific progress and working together to co-define the future of cancer treatments.

All Episodes

Campus PEPtalk

Randomized Controlled Trials for PT: The Gold Standard

July 19, 2022 • IBA / Roberto Orecchia • Season 1 • Episode 10

This episode marks our first episode of Campus PEPTalk Global Edition, our mini-series of PEPTalk episodes dedicated to amplifying the voices of global leaders in the field of Proton Therapy. We are joined by Professor Roberto Orecchia, Scientific Director of European Institute of Oncology Milan to discuss randomized control trials, or “RCTs”, in proton therapy.

The views expressed in this podcast are those of the interviewees. By listening to this, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating. Consult your own physician for any medical issues that you may be having. This entire disclaimer also applies to any guests or contributors to the podcast. Under no circumstances shall Ion Beam Applications SA (IBA), any guests or contributors to the podcast, or any employees, associates, or affiliates of IBA be responsible for damages arising from use of the podcast.